Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Mater Chem B ; 12(23): 5711-5721, 2024 Jun 12.
Article in English | MEDLINE | ID: mdl-38758163

ABSTRACT

The presence of a variety of bacteria is an inevitable/indispensable part of human life. In particular, for patients, the existence and spreading of bacteria lead to prolonged treatment period with many more complications. The widespread use of urinary catheters is one of the main causes for the prevalence of infections. The necessity of long-term use of indwelling catheters is unavoidable in terms of the development of bacteriuria and blockage. As is known, since a permanent solution to this problem has not yet been found, research and development activities continue actively. Herein, polyethylene glycol (PEG)-like thin films were synthesized by a custom designed plasma enhanced chemical vapor deposition (PE-CVD) method and the long-term effect of antifouling properties of PEG-like coated catheters was investigated against Escherichia coli and Proteus mirabilis. The contact angle measurements have revealed the increase of wettability with the increase of plasma exposure time. The antifouling activity of surface-coated catheters was analyzed against the Gram-negative/positive bacteria over a long-term period (up to 30 days). The results revealed that PE-CVD coated PEG-like thin films are highly capable of eliminating bacterial attachment on surfaces with relatively reduced protein attachment without having any toxic effect. Previous statements were supported with SEM, XPS, FTIR spectroscopy, and contact angle analysis.


Subject(s)
Escherichia coli , Polyethylene Glycols , Proteus mirabilis , Surface Properties , Urinary Catheters , Urinary Catheters/microbiology , Escherichia coli/drug effects , Proteus mirabilis/drug effects , Polyethylene Glycols/chemistry , Bacterial Adhesion/drug effects , Biofouling/prevention & control , Humans , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacology
2.
Turk J Med Sci ; 52(3): 834-840, 2022 Jun.
Article in English | MEDLINE | ID: mdl-36326336

ABSTRACT

BACKGROUND: Candida infections are gaining more attention for the last few decades so diagnostic tools are very important for early diagnosis. Conventional identification of yeasts is time-consuming, molecular methods are more complicated and relatively expensive gold-standard methods. Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) was put into the market due to its speed and high accuracy. The aim of this study was to evaluate the performance of corn meal tween-80 agar (CMTA), CHROMagar Candida medium, and MALDI-TOF MS and to compare the obtained results with DNA sequencing. METHODS: The CHROMagar Candida medium, CMTA, and MALDI-TOF MS Biotyper System were used to test 416 isolates. The isolates with discrepant results by at least one of the three methods were subjected to sequence analysis. RESULTS: The identification results of the 351 (%84.4) were compatible with all three methods. When compared to the sequencing results, the most accurate results were obtained by the MALDI-TOF MS, especially for rare Candida species. DISCUSSION: MALDI-TOF MS is found to be the most accurate identification tool for clinically important Candida strains. CMTA alone should not be used for the final identification of Candida species and the chromogenic medium should always be considered presumptive.


Subject(s)
Candida , Candidiasis , Humans , Candida/genetics , Candidiasis/diagnosis , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods
3.
Mikrobiyol Bul ; 56(3): 387-403, 2022 Jul.
Article in Turkish | MEDLINE | ID: mdl-35960233

ABSTRACT

The Coronavirus disease 2019 (COVID-19) pandemic still continues around the world by making peaks with different variants. In the fight against COVID-19, vaccination is currently the only protective measure. In Turkey, vaccination started firstly in healthcare workers on 13 January 2021 with the CoronaVac (Sinovac Biotech, Chinese) vaccine, and booster doses were administered with the CoronaVac and Comirnaty vaccines in July 2021. In this cross-sectional study, it was aimed to determine the humoral and cellular immunity levels of the employees of the TOBB ETU Hospital 2.5-3.5 months after three doses of vaccination and identify the effective factors. With the power analysis that was conducted with the G*Power software, it was determined to be suitable to include 40 TOBB ETU Hospital workers who had their third dose with the CoronaVac vaccine and 60 workers of the same hospital who had their third dose with the Comirnaty (Pfizer Biontech, Germany) vaccine, and age- and sex-matching was considered by selecting 60 workers randomly from among 223 workers who had Comirnaty as their third dose. The study excluded individuals who had a previous COVID-19 infection or had a positive PCR test result. After collecting blood samples on 18-22 October 2021, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) immunoglobulin G levels were studied with the chemiluminescence immunoassay method using a Beckman-Access device (Beckman Coulter Inc., CA, USA) for humoral immunity, and T-SPOT test (T-SPOT. COVID SARS-CoV-2 test-Oxford Immunotec, Singapur) was carried out for cellular immunity. Additionally, demographic data, habits, personal information such as weight and height, reasons for choosing the vaccine and post-vaccine side effects were obtained through the data collection form. Data collection was completed on 29 November 2021. As a result, among the healthcare workers who had received their third dose of vaccine with Comirnaty and CoronaVac; while 25% of those who received three doses of CoronaVac had humoral immunity, 93.3% humoral immunity was determined in the heterogeneous vaccine group with two doses of CoronaVac and one dose of Comirnaty vaccine (p<0.05). Cellular immunity was found to be higher (88.3%, 70%) in those who received the heterologous vaccine than those who completed three doses of the same vaccine (p<0.05). In the heterogeneous vaccination group consisting of the healthcare workers who had their third vaccine dose with Comirnaty and those who had it with CoronaVac, humoral and cellular immunity levels were found high. Among the participants whose humoral immunity was found negative, cellular immunity was present in 75% of those who had Comirnaty as their third dose and 63.3% of those who had CoronaVac. While no significant relationship was found between immunity levels and age, sex or body mass index (BMI), the levels of both forms of immunity were lower in those who had chronic diseases. Among the participants, physicians preferred the third dose of Comirnaty vaccine at a rate of 71.4% and laboratory workers preferred this vaccine at a rate of 80% according to the workplace. In the third dose vaccine preference reasons, it was stated that 55% would continue with the same vaccine, experience fewer side effects, 44% provide more immunity and 9% do not prevent going abroad. The incidence of side effects after the third dose of vaccine was 53% higher in those who received the Comirnaty vaccine than in those who received CoronaVac (35%). Based on these data, it was concluded that heterologous vaccination should be preferred in vaccination strategies, and knowing cellular immunity levels is important for the decision. There is a need for more comprehensive and follow-up studies on how long humoral and especially cellular immunity lasts.


Subject(s)
COVID-19 Vaccines , COVID-19 , Personnel, Hospital , Adult , Antibodies, Viral , COVID-19/immunology , COVID-19/prevention & control , COVID-19 Vaccines/administration & dosage , Cross-Sectional Studies , Female , Humans , Immunity, Cellular , Male , SARS-CoV-2 , Vaccination
4.
Acta Microbiol Immunol Hung ; 68(1): 34-39, 2021 Mar 03.
Article in English | MEDLINE | ID: mdl-33661134

ABSTRACT

After the first description of OXA-48 type carbapenemase, it has become endemic in Europe, Mediterranean and North African countries in a short time. OXA-48 carbapenemase is the most difficult type to determine and accurate diagnosis is crucial especially in endemic areas.The CarbaNP test was described as a rapid phenotypic evaluation method of carbapenemases activity. Sensitivity and specifity of this test were high within all carbapenemases genes. In our study, we evaluated the efficacy of CarbaNP test in routine laboratories located in an endemic area of OXA-48 producing Enterobacterales.A total of 53 Enterobacterales isolates were included in this study. Antimicrobial susceptibility of the isolates to imipenem, meropenem and ertapenem was determined. Polymerase Chain Reaction (PCR) was carried out for the detection of carbapenemases genes (blaKPC, blaNDM, blaBIC, blaIMP, blaVIM, blaSPM, blaAIM, blaDIM, blaGIM, blaSIM, and blaOXA-48). The Carba NP test was performed as in the protocol described previously.Altogether 31 isolates (58.4%) were blaOXA-48 positive (18 Klebsiella pneumoniae, 8 Escherichia coli, 2 Serratia marcescens, 1 Enterobacter aerogenes, 1 Pantoea agglomerans and 1 Morganella morganii). Among these isolates 3 (5.6%) and 2 (3.7%) isolates were also positive for blaVIM and blaSPM, respectively.The sensitivity and specifity of CarbaNP test were found 64.5, and 68.2% respectively. It was observed that determination of positive isolates is hard to distinguish and subjective.The CarbaNP test has suboptimal results and low of sensitivity and specifity for detection of OXA-48 producing Enterobacterales, and not suitable for detection of blaOXA-48 positive isolates in routine laboratories in endemic areas.


Subject(s)
Bacterial Proteins/analysis , Bacterial Proteins/biosynthesis , Carbapenem-Resistant Enterobacteriaceae/enzymology , Enterobacteriaceae Infections/microbiology , beta-Lactamases/analysis , beta-Lactamases/biosynthesis , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Carbapenems/pharmacology , Endemic Diseases , Enterobacteriaceae Infections/epidemiology , Humans , Microbial Sensitivity Tests , Predictive Value of Tests , Sensitivity and Specificity
5.
Int J Pharm ; 587: 119586, 2020 Sep 25.
Article in English | MEDLINE | ID: mdl-32663583

ABSTRACT

Two types of ampicillin carrier platforms were prepared with polycaprolactone (PCL) and the release behavior of a hydrophilic model drug (ampicillin sodium salt) from those matrices was investigated. Spin coating and electrospinning techniques were used to prepare slab and mat platforms, respectively. Ampicillin sodium salt (ASS) at 5% (w:w) concentration was loaded into the slab or mat structures of PCL. The thickness of the slab was measured 3.349 ± 0.345 µm and surface morphology of the slabs showed uniform PCL spherulites. On the other hand, fiber diameter of PCL and ASS loaded PCL (ASSLPCL) was measured 604 ± 176 nm and 549 ± 119 nm, respectively. The dynamic behavior of the controlled release was improved by a very thin film (<100 nm) formation of sulfur hexafluoride (SF6) over the surface via plasma polymerization. Plasma coating was facilitated and speed up the drug diffusion, then led to 45.60 ± 6.46% and 63.67 ± 4.33% enhancement of drug from slab and mat, respectively. Transport mechanism from all matrices showed a Fickian diffusion behavior and plasma modification of the surface did not affected the mechanism. The in vitro antibacterial property of ASS loaded matrices against S. aureus and E. coli was studied through the comparison of bacterial inhibition zones and ASS showed antibacterial effect after all processes.


Subject(s)
Nanofibers , Staphylococcus aureus , Ampicillin , Delayed-Action Preparations , Drug Liberation , Escherichia coli , Polyesters
6.
Scanning ; 2017: 6215482, 2017.
Article in English | MEDLINE | ID: mdl-29279728

ABSTRACT

This study evaluated the antimicrobial efficacy of Er:YAG laser activation with photon-initiated photoacoustic streaming (PIPS), Nd:YAG laser disinfection, and conventional irrigation on Enterococcus faecalis biofilms using scanning electron microscopy (SEM). Biofilms were grown on 110 root halves and divided into the following: Groups 1 and 2 (saline and 1% NaOCl with apical position of PIPS, resp.), Groups 3 and 4 (saline and 1% NaOCl with coronal position of PIPS, resp.), Groups 5 and 6 (Nd:YAG laser after saline and 1% NaOCl irrigation, resp.) and Groups 7, 8, and 9 (conventional irrigation with 1% NaOCl, 6% NaOCl, and saline, resp.). SEM images of the apical, middle, and coronal levels were examined using a scoring system. Score differences between Groups 1 and 2 were insignificant at all levels in the remaining biofilm. Group 4 had significantly greater bacterial elimination than Group 3 at all levels. Differences in Nd:YAG laser irradiation between Groups 5 and 6 were insignificant. Groups 7 and 8 were insignificantly different, except at the middle level. Saline group had a higher percentage of biofilms than the others. In this study, PIPS activation with NaOCl eliminates more E. faecalis biofilms in all root canals regardless of the position of the fiber tip.


Subject(s)
Biofilms/radiation effects , Disinfection/methods , Enterococcus faecalis/physiology , Enterococcus faecalis/radiation effects , Gram-Positive Bacterial Infections/radiotherapy , Lasers, Solid-State/therapeutic use , Tooth Root/microbiology , Humans , Microscopy, Electron, Scanning , Models, Theoretical , Treatment Outcome
7.
Eur J Orthod ; 39(6): 586-594, 2017 Nov 30.
Article in English | MEDLINE | ID: mdl-28402521

ABSTRACT

BACKGROUND: Piezoelectric surgery is a newly introduced technique for rapid tooth movement. However, the efficiency of this technique has not been investigated on en-masse retraction cases yet. OBJECTIVE: To investigate the efficiency of piezosurgery technique in accelerating miniscrew supported en-masse retraction and study the biological tissue response. In addition, to show if this technique induces a difference in dental, skeletal and soft tissue changes on lateral cephalograms, and in canine and molar rotations, besides intercanine and intermolar widths on dental casts. DESIGN, SETTING, PARTICIPANTS: We conducted a randomized, single-centred, parallel-group, controlled trial, requiring upper right and left first premolar extractions on 30 patients above the minimum age of 14 years at the beginning of retraction. INTERVENTIONS: Piezosurgery-assisted versus conventional en-masse retraction anchored from miniscrews placed between second premolars and first molars, bilaterally. OUTCOMES: The main outcome was the en-masse retraction rate. Secondary outcomes were gingival crevicular fluid (GCF) volume and GCF content of receptor activator of nuclear factor κß ligand (RANKL), changes regarding cephalometric and dental cast variables, and miniscrew success rates. RANDOMIZATION: Accomplished with opaque, sealed envelopes. BLINDING: Applicable for data assessment only. RECRUITMENT: Commenced in February 2013 and ended in October 2014. RESULTS: Thirty-one patients were included in the study and divided into 2 groups of piezosurgery (n = 16) and control (n = 15). After 9.3 months of follow-up, no statistically significant difference was observed between groups for neither retraction rates (P = 0.958) nor GCF parameters (P > 0.05). Changes in lateral cephalometric and dental cast variables, and miniscrew success rates did not show significant differences either. CONCLUSION: Based on the results of this study, piezosurgery technique was found to be ineffective in accelerating en-masse retraction, and promoting a difference in the studied GCF parameters, skeletal and dental variables. REGISTRATION: The trial was not registered. PROTOCOL: The full protocol of this PhD thesis study can be accessed from tez.yok.gov.tr. FUNDING: This work was supported by Baskent University Research Fund. No conflict of interest was declared.


Subject(s)
Bone Screws , Orthodontic Anchorage Procedures/instrumentation , Piezosurgery/methods , Tooth Movement Techniques/methods , Adolescent , Adult , Bicuspid/surgery , Cephalometry , Female , Humans , Male , Malocclusion, Angle Class I/surgery , Malocclusion, Angle Class II/surgery , Molar/surgery , Orthodontic Anchorage Procedures/methods , Treatment Outcome , Young Adult
8.
Turk J Med Sci ; 46(3): 877-91, 2016 Apr 19.
Article in English | MEDLINE | ID: mdl-27513269

ABSTRACT

BACKGROUND/AIM: Enterococci play an important role in nosocomial infections. Therefore, this study investigates multidrug resistance (MDR)1 gene areas in the pathogenicity of enterococci and virulence genes in both vancomycin-sensitive enterococci (VSE) and vancomycin-resistant enterococci (VRE) strains. MATERIALS AND METHODS: Virulence genes and MDR genes of enterococci were investigated by polymerase chain reaction (PCR). RESULTS: We evaluated a total of 116 isolates, 93 being VRE and 23 being VSE. In this study, 95.6% of VRE (n = 93) were Enterococcus faecium (n = 89) and 4.3% were E. faecalis (n = 4), while 17.4% of VSE (n = 23) were E. faecium (n = 4) and 82.6% were E. faecalis (n = 19). The vanA MDR1 gene was detected in all VRE isolates. Among virulence genes, esp and hyl were detected in E. faecium, an enterococcus with the highest resistance to vancomycin, and gelE was detected in E. faecalis, an enterococcus with the highest sensitivity to vancomycin. Three or more virulence genes were identified only in VSE strains. We consider that it is a significant result that VSE had more virulence genes than VRE. Only esp was seen in VRE E. faecium strains. CONCLUSION: This study includes experimental results on the association of virulence characteristics in VRE and VSE strains.


Subject(s)
Enterococcus , Anti-Bacterial Agents , Bacterial Proteins , Drug Resistance, Multiple, Bacterial , Genes, MDR , Gram-Positive Bacterial Infections , Humans , Microbial Sensitivity Tests , Polymerase Chain Reaction , Vancomycin , Virulence
9.
Braz. j. microbiol ; 42(1): 243-247, Jan.-Mar. 2011. tab
Article in English | LILACS | ID: lil-571395

ABSTRACT

The stool samples from 245 patients with diarrhea were tested for heat labile toxin (LT) and heat stable toxins (ST) by passive latex agglutination and enzyme immunoassay methods respectively. Twelve (4.9 percent) enterotoxigenic E. Coli ETEC strains were isolated. Five strains (2 percent) expressed ST, and 7 (2.8 percent) expressed LT.


Subject(s)
Humans , Infant, Newborn , Child, Preschool , Child , Clinical Enzyme Tests , Cross-Sectional Studies , Diarrhea, Infantile , Escherichia coli Infections , Enterotoxigenic Escherichia coli/enzymology , Enterotoxigenic Escherichia coli/isolation & purification , Bacterial Toxins/analysis , Bacterial Toxins/isolation & purification , Diagnostic Techniques and Procedures , Immunoassay , Methods , Methods
10.
Article in English | MEDLINE | ID: mdl-21073047

ABSTRACT

Cotinine is a major metabolite of nicotine. This study was planned to investigate the relationship between bronchoalveolar lavage (BAL) fluid cotinine levels and serum cotinine levels in smokers and nonsmokers with various pulmonary diseases and to investigate whether these levels are affected by passive smoking. Serum and BAL fluid cotinine levels were measured in 27 patients. BAL cotinine levels were measured using a sensitive ELISA kit produced to measure cotinine in saliva. Plates were read by microuant (BioTek, USA) micro plate reader. All patient serum cotinine levels were detectable except for one nonsmoker patient. However, BAL fluid cotinine levels were measurable in only 6 patients (two of them were nonsmokers). A significant positive correlation was seen between serum and BAL fluid cotinine levels (r = 0.726; p = 0.000). Serum cotinine levels were significantly higher in present smokers than non-smokers (21.0 +/- 16.01; 5.35 +/- 7.65; p = 0.004). However, there were no significant differences in BAL fluid cotinine levels between smokers and nonsmokers. Passive smoking can increase nicotine metabolites in serum and other body fluids, including BAL fluid. Since BAL fluid and serum cotinine levels were well correlated, there is no need to use invasive procedures, such as bronchoscopy and expensive, time consuming BAL fluid analyses. Serum cotinine levels can give a rough idea of smoking status. BAL fluid cotinine meaurements should be done for only scientific reasons.


Subject(s)
Bronchoalveolar Lavage Fluid/chemistry , Cotinine/analysis , Smoking/metabolism , Bronchoscopy , Cotinine/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/metabolism , Statistics, Nonparametric , Tobacco Smoke Pollution
11.
Clin Invest Med ; 32(6): E232, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-20003827

ABSTRACT

PURPOSE: In vitro antibacterial activity of topical and systemic antihistaminic preparations containing different active substrates against the standard strains of two bacteria was evaluated. METHODS: Four topical and 3 systemic preparations containing pheniramine maleate, chlorophenoxamine hydrochloride, and diphenhydramine hydrochloride were studied. The antibacterial activities of these preparations against strains of S. aureus (American Type Culture Collection, ATCC 29213) and S. epidermidis (ATCC 25212) were tested using the disc diffusion method. In addition, the Minimal Innhibitory Concentration (MIC) and Minimal Bactericidal Concentration (MBC) of parenteral preparations for these two bacteria were determined. RESULTS: Pheniramine maleate-topical and pheniramine maleate-systemic had no activity against bacteria, but the others showed various rates of activity. Chlorophenoxamine hydrochloride-topical and chlorophenoxamine hydrochloride-systemic were the most effective (P < 0.05). Despite the same active substrate content, diphenhydramine hydrochloride-topical-1 and diphenhydramine hydrochloride-topical-2 yielded different results when they were compared with each other or with the other preparations. Diphenhydramine hydrochloride-topical-2 had a relatively higher rate of activity than diphenhydramine hydrochloride-topical-1. Inhibition zone diameters were 16.9+/-1.5 mm 12.3+/-0.5 mm for S .aureus, 17.4+/-1.0 mm 0 mm for S .epidermidis respectively (P < 0.05). MIC values of parenteral preparations were equal to or above 125 ?g/ml. CONCLUSION: MIC values of parenteral preparations were higher than their blood levels in clinical use. Thus, effects of parenteral preparations may not have been reflected in routine clinical practice. However, topical forms have antibacterial activity due to additive substrates and the use of high concentration levels at the site of application. Therefore, in selection of topical forms for appropriate cases, these effects should also be taken into consideration. The antibacterial activity of topical antihistaminic preparations may be useful in certain dermatological pathology.


Subject(s)
Anti-Bacterial Agents/pharmacology , Histamine Antagonists/pharmacology , Microbial Sensitivity Tests , Staphylococcus aureus/drug effects , Staphylococcus epidermidis/drug effects , Diphenhydramine/pharmacology , Ethylamines/pharmacology , Pheniramine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...